U.S. Markets closed
  • S&P 500

    4,473.90
    -6.80 (-0.15%)
     
  • Dow 30

    34,751.12
    -63.27 (-0.18%)
     
  • Nasdaq

    15,181.92
    +20.42 (+0.13%)
     
  • Russell 2000

    2,236.54
    +2.09 (+0.09%)
     
  • Crude Oil

    72.61
    0.00 (0.00%)
     
  • Gold

    1,754.60
    -40.20 (-2.24%)
     
  • Silver

    22.61
    -1.15 (-4.84%)
     
  • EUR/USD

    1.1774
    -0.0052 (-0.4357%)
     
  • 10-Yr Bond

    1.3310
    +0.0270 (+2.07%)
     
  • Vix

    18.37
    +0.19 (+1.05%)
     
  • GBP/USD

    1.3789
    -0.0046 (-0.3323%)
     
  • USD/JPY

    109.7080
    +0.3480 (+0.3182%)
     
  • BTC-USD

    47,500.48
    -562.13 (-1.17%)
     
  • CMC Crypto 200

    1,221.26
    -12.03 (-0.98%)
     
  • FTSE 100

    7,027.48
    +10.99 (+0.16%)
     
  • Nikkei 225

    30,323.34
    -188.36 (-0.62%)
     

Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we'll take a look at whether insiders have been buying or selling shares in IGM Biosciences, Inc. (NASDAQ:IGMS).

Do Insider Transactions Matter?

It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern insider transactions, and certain disclosures are required.

We don't think shareholders should simply follow insider transactions. But equally, we would consider it foolish to ignore insider transactions altogether. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

See our latest analysis for IGM Biosciences

The Last 12 Months Of Insider Transactions At IGM Biosciences

Over the last year, we can see that the biggest insider purchase was by Independent Director M. Behrens for US$4.0m worth of shares, at about US$90.00 per share. So it's clear an insider wanted to buy, at around the current price, which is US$91.30. Of course they may have changed their mind. But this suggests they are optimistic. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. In this case we're pleased to report that the insider bought shares at close to current prices. The only individual insider to buy over the last year was M. Behrens.

M. Behrens purchased 74.44k shares over the year. The average price per share was US$78.22. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that IGM Biosciences insiders own 2.2% of the company, worth about US$64m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The IGM Biosciences Insider Transactions Indicate?

The fact that there have been no IGM Biosciences insider transactions recently certainly doesn't bother us. However, our analysis of transactions over the last year is heartening. Insiders own shares in IGM Biosciences and we see no evidence to suggest they are worried about the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing IGM Biosciences. At Simply Wall St, we found 3 warning signs for IGM Biosciences that deserve your attention before buying any shares.

But note: IGM Biosciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.